喵ID:MDxhPb免责声明

An automated 13.5 hour system for scalable diagnosis and acute management guidance for genetic diseases.

基本信息

DOI:
10.1038/s41467-022-31446-6
发表时间:
2022-07-26
影响因子:
16.6
通讯作者:
中科院分区:
综合性期刊1区
文献类型:
Journal Article
作者: 研究方向: -- MeSH主题词: --
关键词: --
来源链接:pubmed详情页地址

文献摘要

While many genetic diseases have effective treatments, they frequently progress rapidly to severe morbidity or mortality if those treatments are not implemented immediately. Since front-line physicians frequently lack familiarity with these diseases, timely molecular diagnosis may not improve outcomes. Herein we describe Genome-to-Treatment, an automated, virtual system for genetic disease diagnosis and acute management guidance. Diagnosis is achieved in 13.5 h by expedited whole genome sequencing, with superior analytic performance for structural and copy number variants. An expert panel adjudicated the indications, contraindications, efficacy, and evidence-of-efficacy of 9911 drug, device, dietary, and surgical interventions for 563 severe, childhood, genetic diseases. The 421 (75%) diseases and 1527 (15%) effective interventions retained are integrated with 13 genetic disease information resources and appended to diagnostic reports (https://gtrx.radygenomiclab.com). This system provided correct diagnoses in four retrospectively and two prospectively tested infants. The Genome-to-Treatment system facilitates optimal outcomes in children with rapidly progressive genetic diseases. Rapid diagnosis and implementation of treatments is crucial in many genetic conditions. Here the authors describe Genome-to-Treatment, a virtual disease management system that can achieve a rapid diagnosis by expedited whole genome sequencing in 13.5 hours and provide guidance to clinicians for possible therapies.
虽然许多遗传性疾病有有效的治疗方法,但如果不立即实施这些治疗,它们往往会迅速发展为严重的发病状态或导致死亡。由于一线医生往往对这些疾病缺乏了解,及时的分子诊断可能无法改善结果。在此我们描述了“基因组到治疗”(Genome - to - Treatment),这是一个用于遗传性疾病诊断和急性治疗指导的自动化虚拟系统。通过加速全基因组测序,可在13.5小时内完成诊断,对于结构变异和拷贝数变异具有优异的分析性能。一个专家小组对563种严重的儿童遗传性疾病的9911种药物、器械、饮食和手术干预措施的适应证、禁忌证、疗效和疗效证据进行了判定。保留的421种(75%)疾病和1527种(15%)有效干预措施与13种遗传性疾病信息资源整合,并附在诊断报告中(https://gtrx.radygenomiclab.com)。该系统对4例回顾性和2例前瞻性检测的婴儿做出了正确诊断。“基因组到治疗”系统有助于患有快速进展性遗传性疾病的儿童获得最佳治疗效果。 在许多遗传疾病中,快速诊断和实施治疗至关重要。在此作者描述了“基因组到治疗”,这是一个虚拟的疾病管理系统,它可以通过加速全基因组测序在13.5小时内实现快速诊断,并为临床医生提供可能的治疗指导。
参考文献(0)
被引文献(0)
An online compendium of treatable genetic disorders.
DOI:
10.1002/ajmg.c.31874
发表时间:
2021-03
期刊:
American journal of medical genetics. Part C, Seminars in medical genetics
影响因子:
0
作者:
Bick D;Bick SL;Dimmock DP;Fowler TA;Caulfield MJ;Scott RH
通讯作者:
Scott RH
A curated gene list for reporting results of newborn genomic sequencing.
DOI:
10.1038/gim.2016.193
发表时间:
2017-07
期刊:
Genetics in medicine : official journal of the American College of Medical Genetics
影响因子:
0
作者:
Ceyhan-Birsoy O;Machini K;Lebo MS;Yu TW;Agrawal PB;Parad RB;Holm IA;McGuire A;Green RC;Beggs AH;Rehm HL
通讯作者:
Rehm HL
Off-Label Use of Drugs in Children
DOI:
10.1542/peds.2013-4060
发表时间:
2014-03-01
期刊:
PEDIATRICS
影响因子:
8
作者:
Frattarelli, Daniel A. C.;Galinkin, Jeffrey L.;Del Monte, Mark
通讯作者:
Del Monte, Mark
A guide to writing systematic reviews of rare disease treatments to generate FAIR-compliant datasets: building a Treatabolome
DOI:
10.1186/s13023-020-01493-7
发表时间:
2020-08-12
期刊:
ORPHANET JOURNAL OF RARE DISEASES
影响因子:
3.7
作者:
Atalaia, Antonio;Thompson, Rachel;Bonne, Gisele
通讯作者:
Bonne, Gisele
An RCT of Rapid Genomic Sequencing among Seriously Ill Infants Results in High Clinical Utility, Changes in Management, and Low Perceived Harm
DOI:
10.1016/j.ajhg.2020.10.003
发表时间:
2020-11-05
期刊:
AMERICAN JOURNAL OF HUMAN GENETICS
影响因子:
9.8
作者:
Dimmock, David P.;Clark, Michelle M.;Kingsmore, Stephen F.
通讯作者:
Kingsmore, Stephen F.

数据更新时间:{{ references.updateTime }}

关联基金

Precision Medicine in the Diagnosis of Genetic Disorders in Neonates
批准号:
10460478
批准年份:
2018
资助金额:
164.57
项目类别:
通讯地址:
--
所属机构:
--
电子邮件地址:
--
免责声明免责声明
1、猫眼课题宝专注于为科研工作者提供省时、高效的文献资源检索和预览服务;
2、网站中的文献信息均来自公开、合规、透明的互联网文献查询网站,可以通过页面中的“来源链接”跳转数据网站。
3、在猫眼课题宝点击“求助全文”按钮,发布文献应助需求时求助者需要支付50喵币作为应助成功后的答谢给应助者,发送到用助者账户中。若文献求助失败支付的50喵币将退还至求助者账户中。所支付的喵币仅作为答谢,而不是作为文献的“购买”费用,平台也不从中收取任何费用,
4、特别提醒用户通过求助获得的文献原文仅用户个人学习使用,不得用于商业用途,否则一切风险由用户本人承担;
5、本平台尊重知识产权,如果权利所有者认为平台内容侵犯了其合法权益,可以通过本平台提供的版权投诉渠道提出投诉。一经核实,我们将立即采取措施删除/下架/断链等措施。
我已知晓